Association of influenza with severe pneumonia/empyema in the community, hospital, and healthcare-associated setting
- PMID: 27330964
- PMCID: PMC4908279
- DOI: 10.1016/j.rmcr.2016.05.005
Association of influenza with severe pneumonia/empyema in the community, hospital, and healthcare-associated setting
Abstract
We presented three cases of influenza-related severe pneumonia/empyema that occurred in one season.
Case 1: A 76-year-old diabetic man, developed empyema as a result of severe community-acquired pneumonia (CAP) secondary to Haemophilus influenzae, as confirmed on sputum culture. Nasal swab was positive for influenza A antigen. After drainage of empyema, intravenous peramivir and piperacillin/tazobactam were administered for 3 days and 2 weeks, respectively, followed by oral levofloxacin for 2 weeks. Eventually, he recovered. In this case, the isolated H. influenzae was non-typeable and negative for beta-lactamase.
Case 2: A 55-year-old man with suspected cerebral infarction and diabetes mellitus (DM) developed severe pneumonia/empyema as result of hospital-acquired pneumonia (HAP). Although influenza A antigen was detected, no bacterium was isolated from the sputum, blood, or pleural effusion. He showed severe hypoxia, but recovered after administration of peramivir and levofloxacin with prednisolone for 5 days and 2 weeks, respectively.
Case 3: A 76-year-old woman with heart failure and DM was followed-up on an outpatient basis and was under nursing home care for four months. Subsequently, she developed pneumonia and was admitted to our hospital; influenza antigen was isolated from nasal swab. Healthcare-associated pneumonia (HCAP)/empyema were diagnosed and were effectively treated with peramivir and levofloxacin for 4 days and 1 week, respectively. In diabetic patients, influenza virus may possibly accelerate pneumonia/empyema due to bacterial coinfection. Although non-typeable H. influenzae is a rare causative pathogen of empyema, it can be expected as a result of "pathogen shift" due to the increased use of the H. influenzae type b vaccine in Japan.
Keywords: Beta-lactamase negative Haemophilus influenzae; Influenza; Non-typeable Haemophilus influenzae; Vaccine.
Figures
References
-
- Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C. Infectious diseases society of america; american thoracic society., infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007;44:S27–S72. - PMC - PubMed
-
- Glezen W.P., Greenberg S., Atmar R.L., Piedra P.A., Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499–505. - PubMed
-
- Mauad T., Hajjar L., Callegari G.D., da Silva L.F., Schout D., Galas F.R. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 2010;181:72–79. - PubMed
-
- Seki M., KosaiK. Yanagihara K., Higashiyama Y., Kurihara S., Izumikawa K. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern Med. 2007;46:953–958. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous